{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Business/Financial Desk", "lead_paragraph": "Medco Health Solutions, the largest pharmacy benefits management company in the nation, said yesterday that it had agreed to start telling patients, doctors and employers about billions of dollars in annual rebates that it has received from drug manufacturers for promoting their products. The agreement settled state and federal complaints that accused Medco of violating consumer protection and mail fraud laws by switching patients to drugs that were said to add to costs for patients and their health plans.", "headline": {"main": "Medco to Pay $29.3 Million to Settle Complaints of Drug Switching"}, "abstract": "Medco Health Solutions agrees to start telling patients, doctors and employers about billions of dollars in annual rebates that it has received from drug manufacturers for promoting their products; agreement settles state and federal complaints that accused Medco of violating consumer protection and mail fraud laws by switching patients to drugs that were said to add costs for patients and their health plans; state and federal officials say terms of settlement would establish new rules for largely unregulated industry, providing more transparency and prohibiting actions that critics contend favor drug manufacturers at expense of patients; Steven Rowe, attorney general of Maine, says agreement will lift cloak of secrecy around Medco; Medco agrees to change some practices and pay $29.3 million to resolve legal issues; company does not admit any wrongdoing; photo (M)", "print_page": "1", "word_count": 1001, "_id": "4fd239108eb7c8105d7ccb17", "snippet": "Medco Health Solutions, the largest pharmacy benefits management company in the nation, said yesterday that it had agreed to start telling patients, doctors and employers about billions of dollars in annual rebates that it has received from drug...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/04/27/business/medco-to-pay-29.3-million-to-settle-complaints-of-drug-switching.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "ROWE, STEVEN"}, {"name": "glocations", "value": "MAINE"}, {"name": "organizations", "value": "JUSTICE DEPARTMENT"}, {"name": "organizations", "value": "MEDCO HEALTH SOLUTIONS"}, {"name": "subject", "value": "FRAUDS AND SWINDLING"}, {"name": "subject", "value": "REBATES"}, {"name": "subject", "value": "HEALTH INSURANCE AND MANAGED CARE"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "SUITS AND LITIGATION"}, {"name": "subject", "value": "DOCTORS"}, {"name": "subject", "value": "CONSUMER PROTECTION"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Milt", "lastname": "FREUDENHEIM"}], "original": "By MILT FREUDENHEIM"}, "document_type": "article", "pub_date": "2004-04-27T00:00:00Z", "section_name": "Health; Business"}, {"type_of_material": "News", "blog": [], "news_desk": "SundayBusiness", "lead_paragraph": "ADVERTISING has had its share of nasty three-way battles over the years: McDonald's vs. Burger King vs. Wendy's. Bud Light vs. Miller Lite vs. Coors Light. Toyota vs. Nissan vs. Honda. Kellogg's vs. Post vs. General Mills. Now comes Viagra vs. Levitra vs. Cialis. It is a Madison Avenue dream. And nightmare.", "headline": {"main": "Viagra and the Battle of the Awkward Ads"}, "abstract": "Drug makers, planning costly and aggressive advertising drives for drugs to treat erectile dysfunction, have to figure out how to build customer demand and loyalty without offending people or further becoming target of jokes; also face federal rules about advertising content for prescription drugs; analysts say market for Viagra, Levitra and Cialis could more than triple by 2010, to $6 billion, if ad agencies can help destigmatize seeking treatment for problem; ad spending and market share graphs; photos (M)", "print_page": "1", "word_count": 1876, "_id": "4fd23da18eb7c8105d7d3f52", "snippet": "ADVERTISING has had its share of nasty three-way battles over the years: McDonald's vs. Burger King vs. Wendy's. Bud Light vs. Miller Lite vs. Coors Light. Toyota vs. Nissan vs. Honda. Kellogg's vs. Post vs. General Mills.      Now comes Viagra vs....", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2004/04/25/business/viagra-and-the-battle-of-the-awkward-ads.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "SEX"}, {"name": "subject", "value": "CIALIS (DRUG)"}, {"name": "subject", "value": "ADVERTISING AND MARKETING"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "VIAGRA (DRUG)"}, {"name": "subject", "value": "REGULATION AND DEREGULATION OF INDUSTRY"}, {"name": "subject", "value": "LEVITRA (DRUG)"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Stuart", "lastname": "ELLIOTT"}], "original": "By STUART ELLIOTT"}, "document_type": "article", "pub_date": "2004-04-25T00:00:00Z", "section_name": "Health; Business"}], "meta": {"hits": 2, "offset": 0, "time": 40}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}